Cochrane · systematic review · CD013528
Magnetic seizure therapy for treatment‐resistant depression
Jiang, J, Zhang, C, Li, C, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
Common Mental DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
9
current version
GRADE rated
6
No studies
3
Included studies
NR
No studies 3 · 33.3%Ungraded 0 · 0%Very low 6 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings
Population: patients with schizophrenia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
MST vs ECT ‐ symptom severity ‐ HAMD (high = poor; short term) | no estimate extracted | 2 studies · 40 participants | Very low Downgraded: risk of bias, imprecision |
MST vs ECT ‐ cognitive function ‐ immediate memory (high = better; short term) | no estimate extracted | 1 study · 20 participants | Very low Downgraded: risk of bias, imprecision |
MST vs ECT ‐ cognitive function ‐ delayed memory (high = better; short term) | no estimate extracted | 1 study · 20 participants | Very low Downgraded: risk of bias, imprecision |
MST vs ECT ‐ suicides, suicide attempts, self‐harm | no estimate extracted | NR | No studies |
MST vs ECT ‐ quality of life | no estimate extracted | 1 study · 20 participants | Very low Downgraded: risk of bias, imprecision |
MST vs ECT ‐ social functioning | no estimate extracted | NR | No studies |
MST vs ECT ‐ dropout for any reason (short term) | RR 1.38 [0.28, 6.91] | 1 study · 25 participants | Very low Downgraded: risk of bias, imprecision |
MST vs ECT ‐ serious adverse events | no estimate extracted | NR | No studies |
MST vs ECT ‐ adverse events that led to discontinuation of treatment (short term) | 0.19 [0.01, 3.52] | 1 study · 25 participants | Very low Downgraded: risk of bias, imprecision |